compounded semaglutide crackdown news november 2025 🚨 FDA Moves to Shut Down Mass-Market GLP-1s The FDA is taking action to restrict widely marketed, non–FDA-approved compounded GLP-1 products, citing concerns over safety, quality, and misleading claims. As demand glp-1 compounding news november 2025

However, there are few studies in type 1 diabetes, so it is not clear whether this translates into increased rates of DKA." How certain side effects might impact insulin intake Anyone taking GLP-1s will likely experience a reduction in appetite, which is partly why they're so effective at weight reduction

A high-protein diet (0.71.0 grams per pound of ideal body weight) is recommended to preserve lean muscle mass during rapid weight loss

If you want to maintain your current weight, please expect a recommendation that you continue treatments at a maintenance dose with an overall goal of tapering down your dose level, and eventually entering a scenario where you no longer need/want to receive weekly treatments

Hadi, M